European Companies Search Engine
EU funding (€4,699,068): Next Generation BiOactiVe NAnocoatings Hor2 Aug 2022 EU Research and Innovation programme "Horizon"
Text
Next Generation BiOactiVe NAnocoatings
NOVA aims to provide a comprehensive approach to antimicrobial coating development by creating an effective feedback loop between coating design, end use and functional/safety testing. This consists of combinatorial optimisation of 4 coating technologies: i) light activated based on: UV up-converters, nanoscale photocatalysts and hydrophobic carbon-based Quantum Dots and ii) contact killing biopolymers (chain-length controlled supramolecular assemblies of polypeptides and polysaccharides). The coatings will be adjusted in a use case driven specifications for having the capacity to coat different substrates in the same environment such as hospitals. In order to guarantee safety for citizens and environment, the coatings will be developed with a Safe and Sustainable by Design (SSbD) approach taking into account the environmental risks. NOVA will develop advanced tissue tests and immunotoxicity tests optimized for coatings to provide tools for the regulatory bodies an in depth analysis of future coatings. For demonstrating practical efficacy, real-life mimicking, innovative antimicrobial tests will be developed. The validated coatings will be developed for commercial exploitation by upscaling using the capacities of the industrial partners. For easier adoption specific coating application devices will be designed within the project. Finally, the experimental data generated within the project together with the historical data of coating developers of the consortium will be used for developing predictive models using machine learning methodologies for expedited coating development methodologies in the future. NOVA aims to bring high efficiency, eco-friendly, stable coatings demonstrated within the project in 4 main use cases (textiles, paints, tactile electronics and frequently touched hard surfaces with high hygienical relevance like e.g. in hospitals and common hygienical relevance in public spaces) which can be then expanded for more widespread utilization.
Funded Companies:
| Company name | Funding amount |
| EIDGENOSSISCHE MATERIALPRUFUNGS- UND FORSCHUNGSANSTALT | ? |
| AKZO NOBEL DECORATIVE COATINGS B.V. | €136,250 |
| DECHEMA GESELLSCHAFT FUR CHEMISCHETECHNIK UND BIOTECHNOLOGIE | €543,462 |
| Dolmen Design and Innovation Ltd. | €527,122 |
| EVONIK OPERATIONS GmbH | €640,757 |
| FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG e. V. | €932,667 |
| Institut National de la Sante et de la Recherche Medicale | €360,823 |
| Preste | €366,125 |
| Preste LLC | €0.00 |
| SIEMENS HEALTHCARE GmbH | €125,625 |
| Spartha Medical | €613,050 |
| Univerza V Ljubljani | €197,887 |
| Ustav Polymerov Slovenskej Akademievied Verejna Vyskumna Institucia | €255,300 |
Source: https://cordis.europa.eu/project/id/101058554
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: EMPA Eidgenössische Materialprüfungs- und Forschungsanstalt, Dübendorf, Switzerland.
The visualizations for "EIDGENOSSISCHE MATERIALPRUFUNGS- UND FORSCHUNGSANSTALT - EU funding (€4,699,068): Next Generation BiOactiVe NAnocoatings"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
